Skip to content

ARA-290 (Cibinitide)

Research Use Only
peptideInjection

Derived from EPO but modified to activate tissue repair without increasing red blood cells. Protects nerves, fights inflammation. Studied for neuropathy and sarcoidosis.

Key Facts

  • Classification
    Peptide — EPO-derived repair peptide that reduces nerve pain without affecting blood cells.
  • Primary Benefits
    Injury Healing (7/10) · Inflammation (7/10) · Brain & Cognition (5/10)
  • Administration
    Injection
  • Typical Dose
    2-4 mg subq daily for 28 days. Can be repeated after a break.
  • Evidence Strength
    Emerging — 20 peer-reviewed studies referenced · Community sentiment 9/10
  • Stacks Well With
    BPC-157, SS-31
  • Legal Status
    Research Use Only · not prescribable in US

Quick Facts

From price
$75
Type
peptide
Administration
Injection
Evidence
emerging
Studies referenced
20
Community sentiment
9/10
Stacks with
2 peptides
Regulatory
Research Use Only

Top benefits

🩹 Injury Healing
7/10
🧊 Inflammation
7/10
🧠 Brain & Cognition
5/10

Dosing

2-4 mg subq daily for 28 days. Can be repeated after a break.

Benefit Profile

🩹 Injury Healing
7/10
🧊 Inflammation
7/10
🧠 Brain & Cognition
5/10
😌 Mood & Anxiety
4/10